Astrocytoma
Showing 1 - 25 of 748
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)
Active, not recruiting
- Grade III Astrocytoma
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 9, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)
Recruiting
- Glioblastoma
- +3 more
- Adaptive Radiotherapy
-
New York, New YorkColumbia University Irving Medical Center
Oct 27, 2023
Compliance, Patient, Glioblastoma, Astrocytoma, Grade IV Trial (Psychological intervention)
Not yet recruiting
- Compliance, Patient
- +2 more
- Psychological intervention
- (no location specified)
Aug 23, 2023
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Glioma, Pilocytic Astrocytoma, Pilomyxoid Astrocytoma Trial in Rochester, Memphis (Hippocampal-avoidance proton therapy)
Recruiting
- Glioma
- +6 more
- Hippocampal-avoidance proton therapy
-
Rochester, Minnesota
- +1 more
Aug 18, 2022
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)
Recruiting
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
-
New York, New YorkLenox Hill Brain Tumor Center
Nov 10, 2022
IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal
Terminated
- IDH Family Wildtype
- +2 more
- Laser Interstitial Thermal Therapy
- Lomustine
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Vascular Habitats Within Astrocytoma Grade 4 at Molecular,
Recruiting
- Astrocytoma, Grade IV
- +7 more
-
Valencia, SpainBiomedical Data Science Lab. Universitat Politècnica de València
May 11, 2022
Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)
Not yet recruiting
- Astrocytoma
- +2 more
- Craniotomy
- Quantitative Oblique Back-Illumination Microscopy
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2022
Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)
Active, not recruiting
- Astrocytoma, IDH-Mutant, Grade 2
- Astrocytoma, IDH-Mutant, Grade 3
- Questionnaire Administration
- +3 more
-
Phoenix, Arizona
- +24 more
Dec 7, 2022
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)
Not yet recruiting
- Glioblastoma Multiforme
- +4 more
- SIACI of cetuximab and bevacizumab
-
Miami, FloridaJackson Memorial Hospital
Jul 14, 2023
Glioblastoma Trial in Belgium, Germany, Netherlands (CV09050101 mRNA vaccine (CVGBM) 12 µg, CV09050101 mRNA vaccine (CVGBM) 25
Recruiting
- Glioblastoma
- CV09050101 mRNA vaccine (CVGBM) 12 μg
- +5 more
-
Woluwe-Saint-Lambert, Brussels, Belgium
- +14 more
Jul 12, 2023
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Adult Diffuse Glioma Based on Deep Learning
Recruiting
- Astrocytoma
- +2 more
- multi-parametric magnetic resonance imaging scan
- Pathology examination
-
Nanjing, Jiangsu, ChinaDepartment of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022